Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

536 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure.
Tavazzi L, Tognoni G, Franzosi MG, Latini R, Maggioni AP, Marchioli R, Nicolosi GL, Porcu M; GISSI-HF Investigators. Tavazzi L, et al. Among authors: latini r. Eur J Heart Fail. 2004 Aug;6(5):635-41. doi: 10.1016/j.ejheart.2004.03.001. Eur J Heart Fail. 2004. PMID: 15302013 Free article. Clinical Trial.
Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).
Latini R, Masson S, Anand I, Judd D, Maggioni AP, Chiang YT, Bevilacqua M, Salio M, Cardano P, Dunselman PH, Holwerda NJ, Tognoni G, Cohn JN; Valsartan Heart Failure Trial Investigators. Latini R, et al. Circulation. 2002 Nov 5;106(19):2454-8. doi: 10.1161/01.cir.0000036747.68104.ac. Circulation. 2002. PMID: 12417542 Clinical Trial.
Beneficial effects of angiotensin-converting enzyme inhibitor and nitrate association on left ventricular remodeling in patients with large acute myocardial infarction: the Delapril Remodeling after Acute Myocardial Infarction (DRAMI) trial.
Latini R, Staszewsky L, Maggioni AP, Marino P, Hernandez-Bernal F, Tognoni G, Labarta V, Gramenzi S, Bianchi F, Sarcina G, Cremonesi G, Nicolosi GL, Geraci E; Delapril Remodeling after Acute Myocardial Infarction Collaborative Group. Latini R, et al. Am Heart J. 2003 Jul;146(1):133. doi: 10.1016/S0002-8703(02)94777-0. Am Heart J. 2003. PMID: 12851621 Clinical Trial.
Valsartan for the treatment of heart failure.
Latini R, Masson S, Staszewsky L, Maggioni AP. Latini R, et al. Expert Opin Pharmacother. 2004 Jan;5(1):181-93. doi: 10.1517/14656566.5.1.181. Expert Opin Pharmacother. 2004. PMID: 14680446 Review.
Doppler-derived mitral deceleration time as a strong prognostic marker of left ventricular remodeling and survival after acute myocardial infarction: results of the GISSI-3 echo substudy.
Temporelli PL, Giannuzzi P, Nicolosi GL, Latini R, Franzosi MG, Gentile F, Tavazzi L, Maggioni AP; GISSI-3 Echo Substudy Investigators. Temporelli PL, et al. Among authors: latini r. J Am Coll Cardiol. 2004 May 5;43(9):1646-53. doi: 10.1016/j.jacc.2003.12.036. J Am Coll Cardiol. 2004. PMID: 15120826 Free article.
536 results